CHA sent a comment letter to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule that would repay hospitals for underpayments for 340B outpatient drugs from 2018 to 2022 under the Outpatient Prospective Payment System. In addition to making one lump-sum payment to affected 340B hospitals, CMS would also recoup funds from hospitals that received increased rates for non-drug services with a prospective 0.5% cut over the next 16 years. Children’s hospitals would be subject to the 0.5% cut. Our comments oppose the budget neutrality adjustment and urge CMS to consider the unique implications for pediatric care.
CHA Submits Comments on 340B Proposed Rule
Related Content
6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding
Life-changing scientific innovations from children’s hospitals show how public investment changes lives.
Why 340B Is Essential for Children's Health
The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.
CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action
Children's Hospital Association encourages policymakers and leaders to keep investing in better research, innovation, and patient care for children and adolescents with cancer.